National Cancer Institute National Cancer Institute
U.S. National Institutes of Health National Cancer Institute
NCI Home Cancer Topics Clinical Trials Cancer Statistics Research & Funding News About NCI
A Quick Reference Guide for Submitting Clinical Trials to PDQ®
    Updated: 10/14/2004
Quick Links
Director's Corner

Dictionary of Cancer Terms

NCI Drug Dictionary

Funding Opportunities

NCI Publications

Advisory Boards and Groups

Science Serving People

Español
Quit Smoking Today
NCI Highlights
Office of Biorepositories and Biospecimen Research

The Nation's Investment in Cancer Research FY 2010

Report to Nation Finds Declines in Cancer Incidence, Death Rates

Please refer to the tables below for information on how to submit US and Canadian or Non-US trials to PDQ.

CLINICAL TRIAL SOURCE
US & CANADIAN
REVIEW FOR INCLUSION IN PDQ HOW AND WHAT TO SUBMIT
NCI's Cancer Therapy Evaluation Program (CTEP) No Additional Review Required Protocols will be automatically submitted to us by CTEP. You do not need to submit these protocols to us again.
NCI's Center for Cancer Research (CCR) No Additional Review Required Protocols will be automatically submitted to us by CCR. You do not need to submit these protocols to us again.
NCI's CTEP-Cooperative Groups No Additional Review Required Protocols will be automatically submitted to us by CTEP. You do not need to submit these protocols to us again.
NCI's Division of Cancer Prevention (DCP) No Additional Review Required Protocols will be automatically submitted to us by DCP. You do not need to submit these protocols to us again.
NCI-designated clinical & comprehensive cancer centers that have a Protocol Review Monitoring System (PRMS) No Additional Review Required

Submitter must send a copy of PRMS approval along with a completed submission checklist to PDQ Coordinator via fax or mail.

Protocol document may be mailed as a paper document or as a Word or WordPerfect file (on an IBM-formatted diskette). It may also be submitted online or as an attachment via electronic mail.

NCI Sponsored Clinical Trials directly under peer-reviewed NCI grant support (R01, P01, U01, or other NIH grants) No Additional Review Required

Submitter must send a copy of a completed submission checklist to PDQ Coordinator via fax or mail.

Protocol document may be mailed as a paper document or as a Word or WordPerfect file (on an IBM-formatted diskette). It may also be submitted online or as an attachment via electronic mail.

National Cancer Institute of Canada (NCIC) No Additional Review Required

Submitter must send a copy of a completed submission checklist to PDQ Coordinator via fax or mail.

Protocol document may be mailed as a paper document or as a Word or WordPerfect file (on an IBM-formatted diskette). It may also be submitted online or as an attachment via electronic mail

Pharmaceutical Industry sponsored trials submitted to FDA under Investigational New Drug (IND) regulations No Additional Review Required

Submitter must send a completed and signed copy of the PDQ Protocol Notification Agreement along with a completed submission checklist to PDQ Coordinator via fax or mail.

Protocol document may be mailed as a paper document or as a Word or WordPerfect file (on an IBM-formatted diskette). It may also be submitted online or as an attachment via electronic mail.

All Medical Research Institutions conducting trials submitted to FDA under Investigational New Drug (IND) regulations No Additional Review Required

Submitter must send a completed and signed copy of the PDQ Protocol Notification Agreement along with a completed submission checklist to PDQ Coordinator via fax or mail.

Protocol document may be mailed as a paper document or as a Word or WordPerfect file (on an IBM-formatted diskette). It may also be submitted online or as an attachment via electronic mail.

Other NIH-Sponsored Clinical Trials Trials will be reviewed by the PDQ Editorial Board for Voluntary Protocol Review

Submitter must send a completed submission checklist to PDQ Coordinator via fax or mail.

Protocol document may be mailed as a paper document or as a Word or WordPerfect file (on an IBM-formatted diskette) or as an attachment via electronic mail.

All Other Clinical Trials Trials will be reviewed by the PDQ Editorial Board for Voluntary Protocol Review

Submitter must send a completed submission checklist to PDQ Coordinator via fax or mail.

Protocol document may be mailed as a paper document or as a Word or WordPerfect file (on an IBM-formatted diskette) or as an attachment via electronic mail.

If sending hard copy documents, send to:

PDQ Protocol Coordinator
Attn: CIAT
Office of Cancer Content Management, NCI, NIH
6116 Executive Blvd. Suite 3002B MSC-8321
Bethesda, MD 20892-8321

Documents of no more than 20 pages (e.g., the IRB approval) may be faxed to the PDQ Protocol Coordinator at: 301-480-8105

CLINICAL TRIAL SOURCE
EUROPEAN AND OTHER NON-US
REVIEW FOR INCLUSION IN PDQ HOW AND WHAT TO SUBMIT
European Organization for Research and Treatment of Cancer No Additional Review Required Protocols will be automatically submitted to us by EORTC
Cancer Research UK (former Cancer Research Campaign and Imperial Cancer Research Fund) No Additional Review Required *Protocols should be submitted to the NCI Liaison Office. Submitter must send a copy of a completed submission checklist (obtainable on request from the Brussels office) to PDQ Coordinator, Brussels.
United Kingdom Medical Research Council No Additional Review Required *Protocols should be submitted to the NCI Liaison Office. Submitter must send a copy of a completed submission checklist (obtainable on request from the Brussels office) to PDQ Coordinator, Brussels.
United Kingdom Children's Cancer Study Group No Additional Review Required *Protocols should be submitted to the NCI Liaison Office. Submitter must send a copy of a completed submission checklist (obtainable on request from the Brussels office) to PDQ Coordinator, Brussels.
Protocols with certificate of review from Deutsche Krebsgesellschaft(German Cancer Society) No Additional Review Required *Protocols should be submitted to the NCI Liaison Office, Brussels. Submitter must send a copy of a completed submission checklist (obtainable on request from the Brussels office) to PDQ Coordinator, Brussels.
Münchner Studienzentrum der Klinikum rechts der Isar der Technischen Universität München (Munich Clinical Study Group at Munich Technical University) No Additional Review Required *Protocols should be submitted to the NCI Liaison Office, Brussels. Submitter must send a copy of a completed submission checklist (obtainable on request from the Brussels office) to PDQ Coordinator, Brussels.
European Groups not listed above, including
  • Federation Nationale des Centres de Lutte Contre le Cancer(FNCLCC) (National Federation of Centers in the Fight Against Cancer)
  • Stichting Hemato-Oncologie Voor Volwassenen Nederland (HOVON) (Hemato-Oncology Foundation for Adults in the Netherlands)
  • International Breast Cancer Study Group (IBCSG)
  • Irish Clinical Oncology Research Group (ICORG)
  • Dutch Cancer Society (KWF-CKVO)
  • Swiss Institute for Applied Cancer Research (SIAK)
  • Societe Internationale d'Oncologie Pédiatrique (SIOP)(International Society for Pediatric Oncology)
Additional Review Required; Organized by the NCI Liaison Office, Brussels *Protocols should be submitted to the NCI Liaison Office, Brussels. Submitter must send a copy of a completed submission checklist (obtainable on request from the Brussels office) to PDQ Coordinator, Brussels.
Other Non-US Trials Additional Review Required *Submitter must send a copy of a completed submission checklist to PDQ Coordinator via fax or mail.

*Protocol document may be either mailed or sent via electronic mail. Non-English language protocols should also be accompanied by a protocol summary, preferably in English. See "Online PDQ Protocol Submission Instructions" for guidelines on what should be included in the summary.

If sending hard copy documents, send to:

EUROPEAN
PDQ Protocol Coordinator
NCI Liaison Office
Avenue E. Mounier 83/bte 10
B-1200 Brussels
Belgium

Telephone: 322 770 7147
Fax: 322 770 4754
e-mail: nci.lo@eortc.be

OTHER NON-US
PDQ Protocol Coordinator
ATTN: CIAT
Office of Cancer Content Management, NCI, NIH
6116 Executive Blvd. Suite 3002B MSC-8321
Bethesda, MD 20892-8321

Back to TopBack to Top


A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov